PFGIA
ABCL icon

Patriot Financial Group Insurance Agency’s AbCellera Biologics ABCL Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$2K – 2119
2021
Q3 		$2K Buy
+100
New +$1.77K ﹤0.01% 1902

Other funds holding ABCL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DB
DCVC Bio Palo Alto, California $313K AUM
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ABCL Position: Q4 2021 in Review

Patriot Financial Group Insurance Agency sold out of AbCellera Biologics (ABCL) in Q4 2021, closing a stake of 100 shares — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in ABCL in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 124 funds tracked by Wall St. Rank hold ABCL as of Q4 2021.

  • Patriot Financial Group Insurance Agency reported no remaining AbCellera Biologics position as of Q4 2021 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 100 AbCellera Biologics shares in Q4 2021, an estimated $2K.
  • Patriot Financial Group Insurance Agency first reported a position in AbCellera Biologics in Q3 2021 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's AbCellera Biologics position peaked at $2K in Q3 2021.
  • 124 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2021.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2021, filed 10 Jan 2022.